Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H10N2O3S |
Molecular Weight | 274.295 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C1=CC=C2N=C(NC2=C1)C3=CC=CC=C3
InChI
InChIKey=UVCJGUGAGLDPAA-UHFFFAOYSA-N
InChI=1S/C13H10N2O3S/c16-19(17,18)10-6-7-11-12(8-10)15-13(14-11)9-4-2-1-3-5-9/h1-8H,(H,14,15)(H,16,17,18)
DescriptionSources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=611798eb-4004-40e8-b7ff-345136253975Curator's Comment: description was created based on several sources, including:
http://www.ncbi.nlm.nih.gov/pubmed/23112351
Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=611798eb-4004-40e8-b7ff-345136253975
Curator's Comment: description was created based on several sources, including:
http://www.ncbi.nlm.nih.gov/pubmed/23112351
Ensulizole (INN) (phenylbenzimidazole sulfonic acid) is a common sunscreen agent. In 1999, the United States Food and Drug Administration regulated that the name ensulizole be used on sunscreen labels in the United States. It is a selective UVB filter, allowing almost all UVA transmission. The scope of UVB is 290 to 340 nanometers whereas the UVA range is 320 to 400 nanometers. For better UVA protection, it must be paired with avobenzone, titanium dioxide, or zinc oxide; outside of the United States it can also be paired with a UV absorber of the Tinosorb or Mexoryl types. Because is water-soluble, it has the characteristic of feeling lighter on skin. As such, it is often used in sunscreen lotions or moisturizers whose aesthetic goal is a non-greasy finish. The free acid is poorly soluble in water, so it is only used as its soluble salts
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: ultraviolet B Sources: http://www.ncbi.nlm.nih.gov/pubmed/23112351 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | ALOE SUNSCREEN Approved UseUnknown Launch Date2011 |
PubMed
Title | Date | PubMed |
---|---|---|
Sensitive sequential-injection system for the determination of 2-phenylbenzimidazole-5-sulphonic acid in human urine samples using on-line solid-phase extraction coupled with fluorimetric detection. | 2003 Mar 1 |
|
Novel nanotubes from a cationic surfactant and an anionic stiff aromatic counter-ion. | 2006 Sep 14 |
|
Indirect fluorescent determination of selected nitro-aromatic and pharmaceutical compounds via UV-photolysis of 2-phenylbenzimidazole-5-sulfonate. | 2008 Feb 15 |
|
Multiclass determination of sunscreen chemicals in water samples by liquid chromatography-tandem mass spectrometry. | 2008 Feb 15 |
|
Phase behavior of aqueous mixtures of 2-phenylbenzimidazole-5-sulfonic acid and cetyltrimethylammonium bromide: hydrogels, vesicles, tubules, and ribbons. | 2008 Mar 13 |
|
Quantum chemical investigation and experimental verification on the aquatic photochemistry of the sunscreen 2-phenylbenzimidazole-5-sulfonic acid. | 2010 Oct 1 |
|
Occurrence of xenobiotics in gray water and removal in three biological treatment systems. | 2010 Sep 1 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C851
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
||
|
CFR |
21 CFR 352.20
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
||
|
CFR |
21 CFR 352.10
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB11115
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
m4917
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | Merck Index | ||
|
9YQ9DI1W42
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
9YQ9DI1W42
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
CHEMBL1987518
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
3179
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
SUB01893MIG
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
27503-81-7
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
DTXSID3038852
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
7995
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
100000087263
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
1530809
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
33919
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
C83690
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
248-502-0
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
Ensulizole
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
LL-23
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | |||
|
13714
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY | RxNorm | ||
|
C499767
Created by
admin on Sat Dec 16 16:04:32 GMT 2023 , Edited by admin on Sat Dec 16 16:04:32 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)